Approval for the EluNIR Ridaforolimus Eluting Coronary Stent System.  This device is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo lesions <=30mm in length in native coronary arteries with reference diameter of 2.50mm to 4.25mm.